Naegleria infection overview

Jump to navigation Jump to search

Naegleria Infection Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Naegleria Infection from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Naegleria infection overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Naegleria infection overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Naegleria infection overview

CDC on Naegleria infection overview

Naegleria infection overview in the news

Blogs on Naegleria infection overview

Directions to Hospitals Treating Naegleria infection

Risk calculators and risk factors for Naegleria infection overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Naegleria is a free-living amoeba commonly found in the environment in water and soil. Infection of humans is rare but serious. To prevent infection with Naegleria, precautions should be taken to ensure that water does not enter the nose when participating in recreational water sports.

Causes

Only one species (type) of Naegleria infects people: Naegleria fowleri.

Risk Factors

Infection with Naegleria is very rare. However, when it does occur, infection is most common during the dry, summer months, when the air temperature is hot, the water is warm, and water levels are low. The number of infections increase during years characterized by heat waves.

Natural History, Complications and Prognosis

After the start of symptoms, the disease progresses rapidly and usually causes death within about 5 days (range 1 to 12 days).

Diagnosis

History and Symptoms

Naegleria fowleri causes the disease primary amebic meningoencephalitis (PAM), a brain infection that leads to the destruction of brain tissue. In its early stages, symptoms of PAM may be similar to symptoms of bacterial meningitis.

Initial symptoms of PAM start about 5 days (range 1 to 7 days) after infection. The initial symptoms may include headache, fever, nausea, or vomiting. Later symptoms can include stiff neck, confusion, lack of attention to people and surroundings, loss of balance, seizures, and hallucinations.

Laboratory Findings

In Naegleria infections, the diagnosis can be made by microscopic examination of cerebrospinal fluid (CSF). A wet mount may detect motile trophozoites, and a Giemsa-stained smear will show trophozoites with typical morphology. Confocal microscopy or cultivation of the causal organism, and its identification by direct immunofluorescent antibody, may also prove useful. An increasing number of PCR-based techniques (conventional and real-time PCR) have been described for detection and identification of free-living amoebic infections in the clinical samples. Such techniques may be available in selected reference diagnostic laboratories.

Treatment

Medical Therapy

Several drugs are effective against Naegleria fowleri in the laboratory. However, their effectiveness is unclear since almost all infections have been fatal, even when people were treated. Amphotericin B has been successfully used in some cases to treat PAM caused by Naegleria fowleri.

References

Template:WH Template:WS